Latest News
London midday: Stocks turn higher as Rolls-Royce, IAG rally
London stocks had turned higher by midday on Tuesday, helped along by a strong showing from the likes of IAG and Rolls-Royce, although ongoing concerns about the coronavirus pandemic and the looming US stimulus deadline meant gains were unspectacular.
Europe midday: Shares tread water as investors stay cautious
European shares were still struggling for direction at lunchtime on Tuesday as political worries in the UK and US dampened sentiment, while news of further coronavirus restrictions also weighed on investors.
Creditors to take control after Petra secures restructuring deal
Shares in Petra Diamonds lost their sparkle on Tuesday after the mining company abandoned plans to sell the business in favour of a debt-for-equity swap.
Berenberg raises GB Group to 'buy' on multi-year growth story
Analysts at Berenberg hiked their target price on data intelligence outfit GB Group from 680. 0p to 1,020. 0p on Tuesday, stating it was time to buy the company's multi-year growth story.
Asia report: Markets finish mixed as China keeps rates steady
Markets in Asia finished in a mixed state on Tuesday, as China’s central bank sated market expectations by standing pat on interest rates.
Vesuvius reinstates dividend, sending shares higher
Shares in Vesuvius sparked on Tuesday after the engineer confirmed it was reinstating dividend payments.
Open Orphan to assist UK govt in Covid-19 study
Pharmaceutical services company Open Orphan has signed a contract with the UK Government that will see the firm assist in the development of a Covid-19 human challenge study model to safely speed up the development of an efficacious vaccine.
Gamesys expects Q3 results to beat estimates
Gaming technology firm Gamesys reported a "strong performance" in the third quarter on Tuesday, with results for the period now set to come in ahead of expectations.
DotDigital sees FY revenues growing at greater rate than originally expected
Software-as-a-Service provider DotDigital expects to deliver a greater rate of revenue growth in the current trading year than initially expected.
HgCapital Trust puts another £38.8m into the Access Group
HgCapital Trust announced a further investment in business management software provider the Access Group on Tuesday.
BA parent IAG rallies as Heathrow introduces one-hour Covid test
Shares of British Airways and Iberia parent IAG rallied on Tuesday as Heathrow airport launched a one-hour Covid-19 test.
Europe open: Shares struggle for direction on UK, US political worries
European shares drifted lower at the opening on Tuesday as political worries in the UK and US dampened sentiment, while news of further coronavirus restrictions also weighed on investors.
Reckitt lifts revenue guidance as disinfectant demand boosts Q3
Reckitt Benckiser lifted its full-year like-for-like net revenue guidance on Tuesday and posted a jump in third-quarter sales as the Covid-19 pandemic underpinned demand for its disinfection brands.
RWS Holdings' FY revenues set to meet expectations
Intellectual property localisation services firm RWS Holdings said on Tuesday that both full-year revenues and adjusted pre-tax earnings were projected to be in line with expectations.
IntegraFin ends year with record funds under direction
IntegraFin updated the market on funds under direction for its financial adviser platform ‘Transact’ on Tuesday, reporting a 3. 5% improvement over the fourth quarter to £41. 09bn.
London open: Stocks edge lower as US stimulus deadline looms
London stocks edged lower in early trade on Tuesday amid ongoing concerns about the coronavirus pandemic and as investors grew doubtful that a US stimulus package will be agreed before the election.
LXi disposes of three properties, buys two supermarket sites
LXi REIT announced three profitable disposals for a total of £17m on Tuesday, as well as two accretive acquisitions in the foodstore sector, which were being acquired for a total of £15m, reflecting a blended net initial yield of 5. 5%.
AstraZeneca gets FDA nod for Tagrisso in certain lung cancers
AstraZeneca announced on Tuesday that ‘Tagrisso’, or osimertinib, has received acceptance for its supplemental New Drug Application (sNDA), and has also been granted Priority Review in the United States, for the adjuvant treatment of patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), after complete tumour resection with curative intent.
Bellway returns to dividend payouts, Reckitt lifts full-year guidance
London open The FTSE 100 is expected to open 20 points lower on Tuesday, having closed down 0. 59% at 5,884. 65 on Monday.
Britvic 2020 adjusted profit to beat views, PepsiCo agreement announced
Britvic said on Tuesday that adjusted profit for 2020 is expected to be slightly ahead of current market consensus after better-than-expected trading over the summer, as it announced a new and exclusive bottling agreement with PepsiCo.